Oscar Health (NYSE:OSCR) Sets New 12-Month Low - Time to Sell?

Oscar Health, Inc. (NYSE:OSCR - Get Free Report)'s stock price reached a new 52-week low on Thursday . The company traded as low as $12.85 and last traded at $12.54, with a volume of 1260755 shares trading hands. The stock had previously closed at $13.76.

Analyst Upgrades and Downgrades

A number of brokerages have commented on OSCR. Bank of America lowered Oscar Health from a "neutral" rating to an "underperform" rating and decreased their price objective for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Jefferies Financial Group started coverage on Oscar Health in a research note on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price target for the company. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $21.56.

Oscar Health Trading Up 0.5 %

The company has a 50 day moving average of $14.75 and a 200 day moving average of $16.69. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm has a market cap of $3.94 billion, a price-to-earnings ratio of -796.40 and a beta of 1.73.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insider Transactions at Oscar Health

In other news, CFO Richard Scott Blackley sold 25,279 shares of the company's stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $457,044.32. Following the completion of the transaction, the chief financial officer now directly owns 881,841 shares of the company's stock, valued at $15,943,685.28. This represents a 2.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Victoria Baltrus sold 8,078 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $146,050.24. Following the transaction, the chief accounting officer now directly owns 146,036 shares of the company's stock, valued at $2,640,330.88. This trade represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 78,610 shares of company stock worth $1,421,269 over the last 90 days. 25.11% of the stock is owned by insiders.

Hedge Funds Weigh In On Oscar Health

A number of large investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of Oscar Health by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company's stock worth $255,333,000 after purchasing an additional 586,626 shares during the period. Deerfield Management Company L.P. Series C boosted its holdings in shares of Oscar Health by 50.7% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock valued at $159,062,000 after purchasing an additional 3,983,325 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Oscar Health by 348.7% in the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after purchasing an additional 8,051,379 shares in the last quarter. Thrive Capital Management LLC boosted its holdings in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after acquiring an additional 1,588,395 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC boosted its holdings in shares of Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after acquiring an additional 2,151,256 shares in the last quarter. Institutional investors own 75.70% of the company's stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.